Related references
Note: Only part of the references are listed.Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma
Chong Sun et al.
NATURE (2014)
Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4
Pilar Ramos et al.
NATURE GENETICS (2014)
Germ line and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type
Leora Witkowski et al.
NATURE GENETICS (2014)
MAX Inactivation in Small Cell Lung Cancer Disrupts MYC-SWI/SNF Programs and Is Synthetic Lethal with BRG1
Octavio A. Romero et al.
CANCER DISCOVERY (2014)
Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas
Miriam J. Smith et al.
NATURE GENETICS (2013)
OVARIAN SMALL CELL CARCINOMA OF HYPERCALCEMIC TYPE - EVIDENCE OF GERMLINE ORIGIN AND SMARCA4 GENE INACTIVATION. A PILOT STUDY
Jolanta Kupryjanczyk et al.
POLISH JOURNAL OF PATHOLOGY (2013)
MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling
Sidong Huang et al.
CELL (2012)
Understanding resistance to targeted cancer drugs through loss of function genetic screens
Katrien Berns et al.
DRUG RESISTANCE UPDATES (2012)
Somatic Mutations in the Chromatin Remodeling Gene ARID1A Occur in Several Tumor Types
Sian Jones et al.
HUMAN MUTATION (2012)
Targeted exome sequencing in clear cell renal cell carcinoma tumors suggests aberrant chromatin regulation as a crucial step in ccRCC development
Gerben Duns et al.
HUMAN MUTATION (2012)
SWI/SNF Chromatin-remodeling Factors: Multiscale Analyses and Diverse Functions
Ghia Euskirchen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
Anirudh Prahallad et al.
NATURE (2012)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Comprehensive genomic characterization of squamous cell lung cancers
Peter S. Hammerman et al.
NATURE (2012)
Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators
Akihiro Fujimoto et al.
NATURE GENETICS (2012)
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
Cecile Guichard et al.
NATURE GENETICS (2012)
Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes
Zhi Jiang Zang et al.
NATURE GENETICS (2012)
Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers
Ryohei Katayama et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Targeting MET in cancer: rationale and progress
Ermanno Gherardi et al.
NATURE REVIEWS CANCER (2012)
Identification and characterization of novel potentially oncogenic mutations in the human BAF57 gene in a breast cancer patient
M. Angeles Villaronga et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Multiple Mutations and Bypass Mechanisms Can Contribute to Development of Acquired Resistance to MET Inhibitors
Jie Qi et al.
CANCER RESEARCH (2011)
Massive Parallel DNA Pyrosequencing Analysis of the Tumor Suppressor BRG1/SMARCA4 in Lung Primary Tumors
Salvador Rodriguez-Nieto et al.
HUMAN MUTATION (2011)
Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas
Kimberly C. Wiegand et al.
JOURNAL OF PATHOLOGY (2011)
Crizotinib: a novel and first-in-class multitargeted tyrosine kinase inhibitor for the treatment of anaplastic lymphoma kinase rearranged non-small cell lung cancer and beyond
Sai-Hong Ignatius Ou
DRUG DESIGN DEVELOPMENT AND THERAPY (2011)
SWI/SNF nucleosome remodellers and cancer
Boris G. Wilson et al.
NATURE REVIEWS CANCER (2011)
Researchers find a new cancer gene and a possible link between ovarian cancer and endometriosis
[Anonymous]
WOMENS HEALTH (2010)
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
Sian Jones et al.
SCIENCE (2010)
Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer
William Pao et al.
NATURE REVIEWS CANCER (2010)
ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Kimberly C. Wiegand et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
ZNF423 Is Critically Required for Retinoic Acid-induced Differentiation and Is a Marker of Neuroblastoma Outcome
Sidong Huang et al.
CANCER CELL (2009)
RNA interference screening demystified
C. J. Lord et al.
JOURNAL OF CLINICAL PATHOLOGY (2009)
ChIP-seq: Using high-throughput sequencing to discover protein-DNA interactions
Dominic Schmidt et al.
METHODS (2009)
The SWI/SNF complex and cancer
D. Reisman et al.
ONCOGENE (2009)
Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer
Pedro P. Medina et al.
EPIGENETICS (2008)
Changes in the distributions and dynamics of Polycomb repressive complexes during embryonic stem cell differentiation
Xiaojun Ren et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
HER kinase activation confers resistance to MET tyrosine kinase inhibition in MET oncogene-addicted gastric cancer cells
Thomas Bachleitner-Hofmann et al.
MOLECULAR CANCER THERAPEUTICS (2008)
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling
Jeffrey A. Engelman et al.
SCIENCE (2007)
Mechanisms of egfr gene transcription modulation:: Relationship to cancer risk and therapy response
Burkhard Brandt et al.
CLINICAL CANCER RESEARCH (2006)
Identification of BAF57 mutations in human breast cancer cell lines
Evangelos Kiskinis et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Polycomb complexes repress developmental regulators in murine embryonic stem cells
LA Boyer et al.
NATURE (2006)
Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions
AP Bracken et al.
GENES & DEVELOPMENT (2006)
An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors
TR Brummelkamp et al.
NATURE CHEMICAL BIOLOGY (2006)
The c-myc gene is a direct target of mammalian SWI/SNF-related complexes during differentiation-associated cell cycle arrest
NG Nagl et al.
CANCER RESEARCH (2006)
A large-scale RNAi screen in human cells identifies new components of the p53 pathway
K Berns et al.
NATURE (2004)
Role of histone H2A ubiquitination in polycomb silencing
HB Wang et al.
NATURE (2004)
A system for stable expression of short interfering RNAs in mammalian cells
TR Brummelkamp et al.
SCIENCE (2002)
Share Paper
